Cytek Biosciences Sees FY2026 Sales $205.000M-$212.000M vs $207.058M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Cytek Biosciences (NASDAQ:CTKB) sees FY2026 sales of $205.000 million-$212.000 million vs $207.058 million analyst estimate.
Cytek Biosciences (NASDAQ:CTKB) sees FY2026 sales of $205.000 million-$212.000 million vs $207.058 million analyst estimate.